Caffeine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Study to Compare How Different Substances (Caffeine, Warfarin, Omeprazole, Metoprolol, and Midazolam) Are Handled by the Body of Healthy People and People With Liver Cirrhosis
Condition: Liver Cirrhosis Interventions: Drug: Caffeine; Drug: Warfarin sodium; Drug: Omeprazole; Drug: Metoprolol; Drug: Midazolam Sponsor: Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2023 Category: Research Source Type: clinical trials

Improving Cognition With Neurodegradation Countermeasure
Conditions: Hemodynamics; Caffeine; TeaCrine; Cognitive Change Interventions: Dietary Supplement: TeaCrine and Caffeine; Dietary Supplement: Caffeine; Other: Placebo Sponsor: University of South Carolina Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2023 Category: Research Source Type: clinical trials

Pharmacodynamics and Pharmacokinetics of 3 New Developed Coated Glucose Beads in 20 Obese Healthy Subjects
Conditions: Metabolic Syndrome; Obesity Interventions: Drug: coated beads glucose (8 g) and caffeine anhydrous; Drug: coated beads glucose (8 g); Drug: uncoated beads glucose (8 g) and caffeine anhydrous Sponsors: Aphaia Pharma US LLC; ACC GmbH Analytical Clinical Concepts, Germany; Nova-Clin Medical Research Center S.R.L., Romania; BioClinica, Inc.; Galephar Pharmaceutical Research (PR), Inc, Puerto Rico Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2023 Category: Research Source Type: clinical trials